PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Porto Pharmacovigilance Centre, Rua Doutor Plácido da Costa, 4200-450, Porto, Portugal. renato.ivos@gmail.com.\', \'Department of Community Medicine, Health Information and Decision, Porto, Portugal. renato.ivos@gmail.com.\', \'CINTESIS - Center for Health Technology and Services Research, Porto, Portugal. renato.ivos@gmail.com.\', \'Porto Pharmacovigilance Centre, Rua Doutor Plácido da Costa, 4200-450, Porto, Portugal.\', \'Department of Community Medicine, Health Information and Decision, Porto, Portugal.\', \'CINTESIS - Center for Health Technology and Services Research, Porto, Portugal.\', \'Department of Drug Sciences, LAQV/REQUIMTE, Laboratory of Pharmacology, Porto, Portugal.\', \'Department of Medicine, University of Porto, Porto, Portugal.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11096-021-01289-0
?:hasPublicationType
?:journal
  • International journal of clinical pharmacy
is ?:pmid of
?:pmid
?:pmid
  • 34076805
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.702
?:rankingScore_hIndex
  • 51
?:title
  • Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all